BST.MC BME
Biotechnologies Assets S.A.
1W: -6.0%
1M: -11.7%
3M: -12.2%
YTD: -6.0%
1Y: -59.0%
3Y: -56.9%
5Y: -57.8%
€0.19 ($0.21)
+0.00 (+1.06%)
Weekly Expected Move ±5.8%
€0
€0
€0
€0
€0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$3M
-35.7% ▼
5Y CAGR: -43.0%
Gross Profit
$3M
-23.3% ▼
5Y CAGR: -36.7%
Operating Income
$3M
+2.0% ▲
Net Income
-$3M
-285.4% ▼
EPS (Diluted)
$-0.04
-263.7% ▼
EBITDA
-$671K
-113.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $3M | $3M | $3M | $4M | $3M |
| YoY Growth | -94.0% | +22.2% | -15.3% | +49.5% | -35.7% |
| Cost of Revenue | -$197K | $50K | -$21K | $451K | -$138K |
| Gross Profit | $3M | $3M | $3M | $3M | $3M |
| Gross Margin | 107.8% | 98.4% | 100.8% | 88.5% | 105.5% |
| R&D Expenses | $48K | $20K | $18K | $0 | $0 |
| SG&A Expenses | $387K | $953K | $619K | $497K | $465K |
| Operating Expenses | $4M | $5M | $4M | $840K | -$55K |
| Operating Income | -$1M | -$2M | $2M | $3M | $3M |
| Operating Margin | -47.9% | -67.2% | 66.1% | 67.9% | 107.7% |
| Interest Expense | $333K | $855K | $345K | $311K | $181K |
| Income Before Tax | -$2M | -$3M | -$2M | $2M | -$3M |
| Tax Expense | $150K | $103K | -$99K | $749K | -$139K |
| Net Income | -$9M | -$3M | -$2M | $2M | -$3M |
| Net Margin | -340.9% | -97.7% | -74.4% | 40.3% | -116.0% |
| EPS (Diluted) | $-0.22 | $-0.07 | $-0.04 | $0.03 | $-0.04 |
| EBITDA | $993K | -$25K | $450K | $5M | -$671K |
| Shares Outstanding | 39M | 46M | 54M | 58M | 65M |